Healthcare -
Biotechnology - NASDAQ - US
$ 2.47
3.78 %
$ 119 M
Market Cap
-1.79
P/E
SAVA - CAPITAL EXPENDITURES
Capital Expenditures SAVA - Cassava Sciences, Inc.
-414 K
LAST VALUE
86.35%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR